Assertio Holdings (ASRT) Long-Term Debt Repayments (2020 - 2023)
Assertio Holdings' (ASRT) quarterly Long-Term Debt Repayments came in at $10.5 million in Q1 2023, up 50.0% quarter-over-quarter from $7.0 million in Q4 2020.
Assertio Holdings (ASRT) Long-Term Debt Repayments (2020 - 2023) Analysis & Trends
Assertio Holdings has disclosed Long-Term Debt Repayments across 2 years of filings, most recently posting $10.5 million for Q1 2023.
- Long-Term Debt Repayments for Q1 2023 came in at $10.5 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2023 was $10.5 million (up 50.0% YoY), and the FY2023 annual result was $10.5 million, changed N/A from the prior year.
- Long-Term Debt Repayments came in at $10.5 million for Q1 2023 at Assertio Holdings, up from $7.0 million in the prior quarter.
- In the past five years, Long-Term Debt Repayments ranged from a high of $10.5 million in Q1 2023 to a low of -$7.0 million in Q3 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | LT Debt Repayment (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 23.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 216,000.00 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Assertio Holdings | 150.78 Mn | 79.21 Mn | 7.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 10.50 Mn |
| Mar 31, 2023 | 10.50 Mn |
| Dec 31, 2020 | 7.00 Mn |
| Dec 31, 2020 | 7.00 Mn |
| Sep 30, 2020 | -7.00 Mn |
| Sep 30, 2020 | -7.00 Mn |